Studies 59

E-Journals: PubMed Central3

PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “macular degeneration” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for macular degeneration in the PubMed Central database:

•Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. by Marmorstein LY, Munier FL, Arsenijevic Y, Schorderet DF, McLaughlin PJ, Chung D, Traboulsi E, Marmorstein AD.; 2002 Oct 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=130587

•Autologous transplantation of genetically modified iris pigment epithelial cells: A promising concept for the treatment of age-related macular degeneration and other disorders of the eye. by Semkova I, Kreppel F, Welsandt G, Luther T, Kozlowski J, Janicki H, Kochanek S, Schraermeyer U.; 2002 Oct 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=130591

•Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. by Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K.; 2000 Nov 7; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=18837

•Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCRmediated retinal and macular degeneration. by Mata NL, Weng J, Travis GH.; 2000 Jun 20;

http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=16515

•Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. by Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG.; 2002 Nov 12; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=137479

•Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. by Bora PS, Hu Z, Tezel TH, Sohn JH, Kang SG, Cruz JM, Bora NS, Garen A, Kaplan HJ.; 2003 Mar 4; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=151400

•New insights and new approaches toward the study of age-related macular degeneration. by Bok D.; 2002 Nov 12; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=137466

3Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.

4With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age.

5The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.

60 Macular Degeneration

•Risk of macular degeneration in users of statins: cross sectional study. by Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN.; 2001 Aug 18; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=37398

•The Alzheimer's A[beta]-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. by Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH.; 2002 Sep 3; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=129354

•The vitelliform macular dystrophy protein defines a new family of chloride channels. by Sun H, Tsunenari T, Yau KW, Nathans J.; 2002 Mar 19; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=122639

•Therapy for macular degeneration: Insights from acne. by Sparrow JR.; 2003 Apr 15; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=153554

•Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. by Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH.; 2003 Apr 15; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=153626

•Vitamin E supplementation and macular degeneration: randomised controlled trial. by Taylor HR, Tikellis G, Robman LD, McCarty CA, McNeil JJ.; 2002 Jul 6; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=116664

The National Library of Medicine: PubMed

One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals.

To generate your own bibliography of studies dealing with macular degeneration, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “macular degeneration” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for macular degeneration (hyperlinks lead to article summaries):

•A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions.

Author(s): Seddon JM, Santangelo SL, Book K, Chong S, Cote J.

Source: American Journal of Human Genetics. 2003 October; 73(4): 780-90. Epub 2003 August 22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12945014&dopt=Abstract

6 PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.

Studies 61

•A pilot study of ICG-guided laser photocoagulation for occult choroidal neovascularization presenting as a focal spot in age-related macular degeneration.

Author(s): Da Pozzo S, Parodi MB, Ravalico G.

Source: International Ophthalmology. 2001; 24(4): 187-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12678394&dopt=Abstract

•A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.

Author(s): Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F.

Source: Archives of Ophthalmology. 2003 May; 121(5): 667-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12742844&dopt=Abstract

•Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration.

Author(s): Gupta N, Brown KE, Milam AH.

Source: Experimental Eye Research. 2003 April; 76(4): 463-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12634111&dopt=Abstract

•Adult vitelliform macular degeneration: a clinicopathological study.

Author(s): Arnold JJ, Sarks JP, Killingsworth MC, Kettle EK, Sarks SH. Source: Eye (London, England). 2003 August; 17(6): 717-26.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12928683&dopt=Abstract

•Advanced glycation end products in age-related macular degeneration.

Author(s): Ishibashi T, Murata T, Hangai M, Nagai R, Horiuchi S, Lopez PF, Hinton DR, Ryan SJ.

Source: Archives of Ophthalmology. 1998 December; 116(12): 1629-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9869793&dopt=Abstract

•Age related macular degeneration: macular relocation surgery was not taken into account.

Author(s): Wong D, Charteris DG, da Cruz L.

Source: Bmj (Clinical Research Ed.). 2003 June 28; 326(7404): 1459; Author Reply 1459-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12829574&dopt=Abstract

•Age related macular degeneration: smoking entails major risk of blindness.

Author(s): Kelly SP, Edwards R, Elton P, Mitchell P.

Source: Bmj (Clinical Research Ed.). 2003 June 28; 326(7404): 1458-9; Author Reply 145960. Erratum In: Bmj. 2003 August 9; 327(7410): 325. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12829572&dopt=Abstract

62 Macular Degeneration

•Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials.

Author(s): Bartlett H, Eperjesi F.

Source: Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 2003 September; 23(5): 383-99. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12950886&dopt=Abstract

•Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

Author(s): Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Source: Survey of Ophthalmology. 2003 May-June; 48(3): 257-93. Review.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12745003&dopt=Abstract

•Age-related macular degeneration: review of pathogenesis.

Author(s): Zarbin MA.

Source: Eur J Ophthalmol. 1998 October-December; 8(4): 199-206. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9891890&dopt=Abstract

•Age-related macular degeneration--a genome scan in extended families.

Author(s): Majewski J, Schultz DW, Weleber RG, Schain MB, Edwards AO, Matise TC, Acott TS, Ott J, Klein ML.

Source: American Journal of Human Genetics. 2003 September; 73(3): 540-50. Epub 2003 July 25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12900797&dopt=Abstract

•Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration.

Author(s): Stone EM, Webster AR, Vandenburgh K, Streb LM, Hockey RR, Lotery AJ, Sheffield VC.

Source: Nature Genetics. 1998 December; 20(4): 328-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9843201&dopt=Abstract

•Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.

Author(s): Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL. Source: Molecular Vision [electronic Resource]. 2003 May 14; 9: 184-90.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12764254&dopt=Abstract

Studies 63

•Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

Author(s): D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group.

Source: Retina (Philadelphia, Pa.). 2003 February; 23(1): 14-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12652226&dopt=Abstract

•Angiographic characteristics in patients undergoing macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Author(s): Kent DL, Fujii GY, Pieramici DJ, Reynolds SM, Melia M, Rossi JV, Humayun MS, Caffey S, De Juan E.

Source: Retina (Philadelphia, Pa.). 2003 April; 23(2): 152-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12707592&dopt=Abstract

•Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.

Author(s): Csaky K.

Source: Ophthalmology. 2003 May; 110(5): 879-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12750083&dopt=Abstract

•Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

Author(s): Eyetech Study Group.

Source: Ophthalmology. 2003 May; 110(5): 979-86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12750101&dopt=Abstract

•Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up.

Author(s): van Meurs JC, Van Den Biesen PR.

Source: American Journal of Ophthalmology. 2003 October; 136(4): 688-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14516809&dopt=Abstract

•Autosomal dominant macular degeneration associated with 208delG mutation in the FSCN2 gene.

Author(s): Wada Y, Abe T, Itabashi T, Sato H, Kawamura M, Tamai M. Source: Archives of Ophthalmology. 2003 November; 121(11): 1613-20.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14609921&dopt=Abstract

64 Macular Degeneration

•Benefit of coloured lenses for age-related macular degeneration.

Author(s): Wolffsohn JS, Dinardo C, Vingrys AJ.

Source: Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 2002 July; 22(4): 300-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12162481&dopt=Abstract

•Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors.

Author(s): Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm IH, Bird AC.

Source: Ophthalmology. 1994 September; 101(9): 1522-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8090455&dopt=Abstract

•Binocular contrast inhibition in subjects with age-related macular degeneration.

Author(s): Valberg A, Fosse P.

Source: J Opt Soc Am a Opt Image Sci Vis. 2002 January; 19(1): 223-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11778728&dopt=Abstract

•Biochemical defects in retina-specific human ATP binding cassette transporter nucleotide binding domain 1 mutants associated with macular degeneration.

Author(s): Suarez T, Biswas SB, Biswas EE.

Source: The Journal of Biological Chemistry. 2002 June 14; 277(24): 21759-67. Epub 2002 March 27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11919200&dopt=Abstract

•Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCRmediated retinal and macular degeneration.

Author(s): Mata NL, Weng J, Travis GH.

Source: Proceedings of the National Academy of Sciences of the United States of America. 2000 June 20; 97(13): 7154-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10852960&dopt=Abstract

•Brachytherapy--optional treatment for choroidal neovascularization secondary to agerelated macular degeneration.

Author(s): Saric B, Sikic J, Katusic D, Vukojevic N. Source: Coll Antropol. 2001; 25 Suppl: 89-96.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11817022&dopt=Abstract

Studies 65

•By the way doctor. I'm 72 and was recently told that I am losing a bit of my sight because of macular degeneration. My doctor assured me that it was progressing very slowly, but also said there wasn't really anything to do about it. But I read that zinc or vitamins might help. Should I be taking them?

Author(s): Lee TH.

Source: Harvard Health Letter / from Harvard Medical School. 2002 February; 27(4): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11869993&dopt=Abstract

•Case-control study of the risk factors for age related macular degeneration. FranceDMLA Study Group.

Author(s): Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, Bourguignon C, Harpey C, Brault Y, Coste M, Moccatti D, Bourgeois H.

Source: The British Journal of Ophthalmology. 1998 September; 82(9): 996-1002. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9893587&dopt=Abstract

•Cataract extraction and age-related macular degeneration: associations, diagnosis and management.

Author(s): Velez G, Weiter JJ.

Source: Seminars in Ophthalmology. 2002 September-December; 17(3-4): 187-95. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12759849&dopt=Abstract

•Cataract surgery and quality of life in patients with age related macular degeneration.

Author(s): Lundstrom M, Brege KG, Floren I, Lundh B, Stenevi U, Thorburn W. Source: The British Journal of Ophthalmology. 2002 December; 86(12): 1330-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12446358&dopt=Abstract

•Cataract surgery in patients with age-related macular degeneration: one-year outcomes.

Author(s): Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Source: Journal of Cataract and Refractive Surgery. 2003 April; 29(4): 686-93.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12686235&dopt=Abstract

•Changes in blood antioxidants and several lipid peroxidation products in women with age-related macular degeneration.

Author(s): Nowak M, Swietochowska E, Wielkoszynski T, Marek B, Karpe J, Gorski J, Glogowska-Szelag J, Kos-Kudla B, Ostrowska Z.

Source: Eur J Ophthalmol. 2003 April; 13(3): 281-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12747649&dopt=Abstract

66 Macular Degeneration

•Changes in fluorescein angiogram early after surgical removal of choroidal neovascularization in age-related macular degeneration.

Author(s): Sawa M, Kamei M, Ohji M, Motokura M, Saito Y, Tano Y.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 January; 240(1): 12-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11954774&dopt=Abstract

•Cigarette smoking as a risk factor for cataract and age-related macular degeneration: a review of the literature.

Author(s): DeBlack SS.

Source: Optometry. 2003 February; 74(2): 99-110. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585737&dopt=Abstract

•Clinical observations supporting a theoretical model of choriocapillaris blood flow in treatment of choroidal neovascularization associated with age-related macular degeneration.

Author(s): Staurenghi G, Flower RW.

Source: American Journal of Ophthalmology. 2002 June; 133(6): 801-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12036672&dopt=Abstract

•Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine.

Author(s): Klingel R, Fassbender C, Fassbender T, Gohlen B.

Source: Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. 2003 August; 29(1): 71-84. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12877897&dopt=Abstract

•Clinicopathologic correlation in hemorrhagic age-related macular degeneration.

Author(s): Reynders S, Lafaut BA, Aisenbrey S, Broecke CV, Lucke K, Walter P, Kirchhof B, Bartz-Schmidt KU.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 April; 240(4): 279-85. Epub 2002 March 07. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11981641&dopt=Abstract

Studies 67

•Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.

Author(s): Aisenbrey S, Lafaut BA, Reynders S, Szurman P, Grisanti S, Vanden Broecke C, Walter P, Bartz-Schmidt KU.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2003 April; 241(4): 269-76. Epub 2003 March 22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12719987&dopt=Abstract

•Clusterin is present in drusen in age-related macular degeneration.

Author(s): Sakaguchi H, Miyagi M, Shadrach KG, Rayborn ME, Crabb JW, Hollyfield JG. Source: Experimental Eye Research. 2002 April; 74(4): 547-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12076098&dopt=Abstract

•Color Doppler imaging of choroidal circulation in patients with asymmetric agerelated macular degeneration.

Author(s): Uretmen O, Akkin C, Erakgun T, Killi R.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2003 March-April; 217(2): 137-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12592053&dopt=Abstract

•Color Doppler imaging of the retrobulbar circulation in age-related macular degeneration.

Author(s): Hosal BM, Karakoc G, Gursel E, Camur M.

Source: Eur J Ophthalmol. 1998 October-December; 8(4): 234-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9891895&dopt=Abstract

•Comment on “Mathematical morphology in computerized analysis of angiograms in age-related macular degeneration”.

Author(s): Hutchinson TP.

Source: Medical Physics. 2002 December; 29(12): 2960; Author Reply 2961. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12512734&dopt=Abstract

•Cone dysfunction in patients with late-onset cone dystrophy and age-related macular degeneration.

Author(s): Ladewig M, Kraus H, Foerster MH, Kellner U.

Source: Archives of Ophthalmology. 2003 November; 121(11): 1557-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14609911&dopt=Abstract

•Could statins prevent age-related macular degeneration?

Author(s): Hall NF, Martyn CN.

Source: Expert Opinion on Pharmacotherapy. 2002 July; 3(7): 803-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12083981&dopt=Abstract

68 Macular Degeneration

•Cultivation of retinal pigment epithelial cells from human choroidal neovascular membranes in age related macular degeneration.

Author(s): Schlunck G, Martin G, Agostini HT, Camatta G, Hansen LL. Source: Experimental Eye Research. 2002 May; 74(5): 571-6.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12076078&dopt=Abstract

•Current use of dietary supplementation in patients with age-related macular degeneration.

Author(s): Chang CW, Chu G, Hinz BJ, Greve MD. Source: Can J Ophthalmol. 2003 February; 38(1): 27-32.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12608514&dopt=Abstract

•Cystoid macular degeneration in chronic central serous chorioretinopathy.

Author(s): Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Source: Retina (Philadelphia, Pa.). 2003 February; 23(1): 1-7; Quiz 137-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12652224&dopt=Abstract

•Dark adaptation in age-related macular degeneration: relationship to the fellow eye.

Author(s): Haimovici R, Owens SL, Fitzke FW, Bird AC.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 February; 240(2): 90-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931085&dopt=Abstract

•Decreased visual acuity associated with cystoid macular edema in neovascular agerelated macular degeneration.

Author(s): Ting TD, Oh M, Cox TA, Meyer CH, Toth CA. Source: Archives of Ophthalmology. 2002 June; 120(6): 731-7.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12049577&dopt=Abstract

•Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.

Author(s): Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D, Rapaport MH, Kaplan RM, Brown SI.

Source: Ophthalmology. 2001 October; 108(10): 1893-900; Discussion 1900-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11581068&dopt=Abstract

•Detachment of subfoveal choroidal neovascularization in age-related macular degeneration.

Author(s): Rumelt S, Kaiserman I, Rehany U, Ophir A, Pikkel J, Loewenstein A. Source: American Journal of Ophthalmology. 2002 December; 134(6): 822-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12470749&dopt=Abstract

Studies 69

•Detection and segmentation of drusen deposits on human retina: potential in the diagnosis of age-related macular degeneration.

Author(s): Rapantzikos K, Zervakis M, Balas K.

Source: Medical Image Analysis. 2003 March; 7(1): 95-108. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12467724&dopt=Abstract

•Detection of drusen in the fellow eye of Japanese patients with age-related macular degeneration using scanning laser ophthalmoscopy.

Author(s): Ishiko S, Akiba J, Horikawa Y, Yoshida A. Source: Ophthalmology. 2002 November; 109(11): 2165-9.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12414434&dopt=Abstract

•Development of a health education programme for elderly with age-related macular degeneration: a focus group study.

Author(s): Dahlin-Ivanoff S, Klepp KI, Sjostrand J.

Source: Patient Education and Counseling. 1998 May; 34(1): 63-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9697558&dopt=Abstract

•Development of an ADL instrument targeting elderly persons with age-related macular degeneration.

Author(s): Dahlin-Ivanoff S, Sonn U, Svensson E.

Source: Disability and Rehabilitation. 2001 January 20; 23(2): 69-79. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11214718&dopt=Abstract

•Development of exudative age-related macular degeneration after cataract surgery.

Author(s): Pollack A, Marcovich A, Bukelman A, Zalish M, Oliver M. Source: Eye (London, England). 1997; 11 ( Pt 4): 523-30.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9425419&dopt=Abstract

•Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research.

Author(s): Cooper DA, Eldridge AL, Peters JC.

Source: Nutrition Reviews. 1999 July; 57(7): 201-14. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10453174&dopt=Abstract

•Dietary fat and risk for advanced age-related macular degeneration.

Author(s): Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, Willett W.

Source: Archives of Ophthalmology. 2001 August; 119(8): 1191-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11483088&dopt=Abstract

70 Macular Degeneration

•Dietary prevention of age-related macular degeneration.

Author(s): Pratt S.

Source: J Am Optom Assoc. 1999 January; 70(1): 39-47. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10457680&dopt=Abstract

•Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration.

Author(s): Brown GC, Brown MM, Sharma S. Source: Can J Ophthalmol. 2000 April; 35(3): 127-33.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10812481&dopt=Abstract

•Do age-related macular degeneration and cardiovascular disease share common antecedents?

Author(s): Snow KK, Seddon JM.

Source: Ophthalmic Epidemiology. 1999 June; 6(2): 125-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10420212&dopt=Abstract

•Does coenzyme Q10 play a role in opposing oxidative stress in patients with agerelated macular degeneration?

Author(s): Blasi MA, Bovina C, Carella G, Genova ML, Jansen AM, Lenaz G, Brancato R. Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2001 January-February; 215(1): 51-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11125270&dopt=Abstract

•Dosimetric advantages of enhanced dynamic wedge in small field irradiation for the treatment of macular degeneration.

Author(s): Edlund T, Leavitt DD, Gibbs FA Jr.

Source: Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 1999 Spring; 24(1): 21-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10100161&dopt=Abstract

•Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.

Author(s): Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO. Source: Experimental Eye Research. 2002 January; 74(1): 141-54.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11878827&dopt=Abstract

Studies 71

•Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.

Author(s): Mullins RF, Russell SR, Anderson DH, Hageman GS.

Source: The Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2000 May; 14(7): 835-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10783137&dopt=Abstract

•Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression.

Author(s): Abdelsalam A, Del Priore L, Zarbin MA.

Source: Survey of Ophthalmology. 1999 July-August; 44(1): 1-29. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10466585&dopt=Abstract

•Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Author(s): Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG.

Source: Proceedings of the National Academy of Sciences of the United States of America. 2002 November 12; 99(23): 14682-7. Epub 2002 October 21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12391305&dopt=Abstract

•Early detection and treatment of neovascular age-related macular degeneration.

Author(s): Bressler NM.

Source: The Journal of the American Board of Family Practice / American Board of Family Practice. 2002 March-April; 15(2): 142-52. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12002198&dopt=Abstract

•Early detection, diagnosis and management of choroidal neovascularization in agerelated macular degeneration: the role of ophthalmologists.

Author(s): Sickenberg M.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2001 July-August; 215(4): 247-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11399930&dopt=Abstract

•Effect of depression on vision function in age-related macular degeneration.

Author(s): Rovner BW, Casten RJ, Tasman WS.

Source: Archives of Ophthalmology. 2002 August; 120(8): 1041-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12149057&dopt=Abstract

72 Macular Degeneration

•Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Author(s): Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donati G, Hao Y, Ma C, Menchini U, Miller J, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Strong HA, Stur M, Su XY, Virgili G; Treatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study group.

Source: American Journal of Ophthalmology. 2003 September; 136(3): 407-18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12967792&dopt=Abstract

•Effect of unilateral exudative age-related macular degeneration on binocular visual function.

Author(s): Quillen DA.

Source: Archives of Ophthalmology. 2001 November; 119(11): 1725-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11709032&dopt=Abstract

•Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration.

Author(s): Penfold PL, Wong JG, Gyory J, Billson FA.

Source: Clinical & Experimental Ophthalmology. 2001 June; 29(3): 188-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11446466&dopt=Abstract

•Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

Author(s): Rubin GS, Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic therapy (TAP) study group.

Source: Retina (Philadelphia, Pa.). 2002 October; 22(5): 536-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12441717&dopt=Abstract

•Efficacy of iloprost in nonexudative, age-related macular degeneration.

Author(s): Gerardino L, Santoliquido A, Flore R, Dal Lago A, Gaetani E, Gasbarrini A, Papaleo P, Abed A, Pola R.

Source: Journal of the American Geriatrics Society. 2000 October; 48(10): 1350-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11037033&dopt=Abstract

•Electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration.

Author(s): Luke C, Aisenbrey S, Luke M, Marzella G, Bartz-Schmidt KU, Walter P. Source: The British Journal of Ophthalmology. 2001 August; 85(8): 928-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11466247&dopt=Abstract

Studies 73

•Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.

Author(s): Haddad WM, Coscas G, Soubrane G.

Source: The British Journal of Ophthalmology. 2002 June; 86(6): 663-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12034690&dopt=Abstract

•Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration.

Author(s): Sauer CG, White K, Stohr H, Grimm T, Hutchinson A, Bernstein PS, Lewis RA, Simonelli F, Pauleikhoff D, Allikmets R, Weber BH.

Source: The British Journal of Ophthalmology. 2001 August; 85(8): 969-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11466257&dopt=Abstract

•Evolving pathophysiological paradigms for age related macular degeneration.

Author(s): Ciulla TA.

Source: The British Journal of Ophthalmology. 2001 May; 85(5): 510-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11316702&dopt=Abstract

•Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration.

Author(s): Honda M, Sakamoto T, Ishibashi T, Inomata H, Ueno H. Source: Gene Therapy. 2000 June; 7(11): 978-85.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10849558&dopt=Abstract

•Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in agerelated macular degeneration.

Author(s): Kadonosono K, Yazama F, Itoh N, Sawada H, Ohno S.

Source: American Journal of Ophthalmology. 1999 September; 128(3): 382-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10511046&dopt=Abstract

•External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial.

Author(s): Marcus DM, Sheils W, Johnson MH, McIntosh SB, Leibach DB, Maguire A, Alexander J, Samy CN.

Source: Archives of Ophthalmology. 2001 February; 119(2): 171-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11176977&dopt=Abstract

74 Macular Degeneration

•External beam radiation in patients suffering from exudative age-related macular degeneration. A matched-pairs study and 1-year clinical follow-up.

Author(s): Krott R, Staar S, Muller RP, Bartz-Schmidt KU, Esser P, Heimann K.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1998 December; 236(12): 916-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9865622&dopt=Abstract

•External beam radiotherapy for subretinal neovascularization in age-related macular degeneration: is this treatment efficient?

Author(s): Staar S, Krott R, Mueller RP, Bartz-Schmidt KU, Heimann K.

Source: International Journal of Radiation Oncology, Biology, Physics. 1999 September 1; 45(2): 467-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10487573&dopt=Abstract

•External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data.

Author(s): Chakravarthy U, MacKenzie G.

Source: The British Journal of Radiology. 2000 March; 73(867): 305-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10817048&dopt=Abstract

•Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Author(s): Penfold PL, Gyory JF, Hunyor AB, Billson FA.

Source: Australian and New Zealand Journal of Ophthalmology. 1995 November; 23(4): 293-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11980075&dopt=Abstract

•Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Author(s): Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA.

Source: Australian and New Zealand Journal of Ophthalmology. 1998 November; 26(4): 277-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9843254&dopt=Abstract

•Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device.

Author(s): Tejeria L, Harper RA, Artes PH, Dickinson CM.

Source: The British Journal of Ophthalmology. 2002 September; 86(9): 1019-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12185131&dopt=Abstract

Studies 75

•Factors influencing visual acuity after photocoagulation for subfoveal choroidal neovascularization of exudative age-related macular degeneration.

Author(s): Yuzawa M, Tamakoshi A, Ueha M, Kawakubo H, Nakajima M. Source: Ophthalmology. 1996 December; 103(12): 2037-41.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9003337&dopt=Abstract

•Features of age-related macular degeneration on optical coherence tomography.

Author(s): Van Kerckhoven W, Lafaut B, Follens I, De Laey JJ. Source: Bull Soc Belge Ophtalmol. 2001; (281): 75-84.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11702647&dopt=Abstract

•Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Author(s): Shiraga F, Ojima Y, Matsuo T, Takasu I, Matsuo N. Source: Ophthalmology. 1998 April; 105(4): 662-9.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9544641&dopt=Abstract

•Findings on retinal topography and thickness mapping in age-related macular degeneration.

Author(s): Gieser JP, Mori M, Blair NP, Shahidi M. Source: Retina (Philadelphia, Pa.). 2001; 21(4): 352-60.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11508882&dopt=Abstract

•Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease.

Author(s): Sunness JS, Applegate CA, Haselwood D, Rubin GS. Source: Ophthalmology. 1996 September; 103(9): 1458-66.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8841306&dopt=Abstract

•Fluorescent pigments of the retinal pigment epithelium and age-related macular degeneration.

Author(s): Ben-Shabat S, Parish CA, Hashimoto M, Liu J, Nakanishi K, Sparrow JR. Source: Bioorganic & Medicinal Chemistry Letters. 2001 June 18; 11(12): 1533-40. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11412975&dopt=Abstract

•Focal electroretinograms and fundus appearance in nonexudative age-related macular degeneration. Quantitative relationship between retinal morphology and function.

Author(s): Falsini B, Serrao S, Fadda A, Iarossi G, Porrello G, Cocco F, Merendino E. Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1999 March; 237(3): 193-200. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10090581&dopt=Abstract

76 Macular Degeneration

•Formation of a nonaoxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement.

Author(s): Ben-Shabat S, Itagaki Y, Jockusch S, Sparrow JR, Turro NJ, Nakanishi K. Source: Angewandte Chemie (International Ed. in English). 2002 March 1; 41(5): 814-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12491345&dopt=Abstract

•Foveal congenital hypertrophy of the retinal pigment epithelium in the setting of geographic atrophy from age-related macular degeneration.

Author(s): Apte RS, Bressler NM.

Source: American Journal of Ophthalmology. 2003 January; 135(1): 120-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12504720&dopt=Abstract

•Foveal translocation for exudative age related macular degeneration.

Author(s): McLeod D.

Source: The British Journal of Ophthalmology. 2000 April; 84(4): 344-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10729288&dopt=Abstract

•Foveal translocation surgery in age-related macular degeneration.

Author(s): Cekic O, Ohji M, Hayashi A, Fujikado T, Tano Y. Source: Lancet. 1999 July 24; 354(9175): 340.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10440341&dopt=Abstract

•Foveolar choroidal blood flow in age-related macular degeneration.

Author(s): Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM, Ho AC.

Source: Investigative Ophthalmology & Visual Science. 1998 February; 39(2): 385-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9477998&dopt=Abstract

•Frequency doubling technology perimetry in age-related macular degeneration.

Author(s): Sheu SJ, Chen YY, Chou LC, Wu TT, Cheng KK.

Source: Zhonghua Yi Xue Za Zhi (Taipei). 2002 September; 65(9): 435-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12433030&dopt=Abstract

•Functional analysis after auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration.

Author(s): Abe T, Yoshida M, Tomita H, Kano T, Nakagawa Y, Sato M, Wada Y, Fuse N, Yamada T, Tamai M.

Source: The Tohoku Journal of Experimental Medicine. 1999 December; 189(4): 295-305. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10739165&dopt=Abstract

Studies 77

•Fundus autofluorescence and age-related macular degeneration.

Author(s): Spaide RF.

Source: Ophthalmology. 2003 February; 110(2): 392-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12578786&dopt=Abstract

•Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Author(s): Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE.

Source: Investigative Ophthalmology & Visual Science. 2001 April; 42(5): 1051-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11274085&dopt=Abstract

•Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss.

Author(s): Lois N, Owens SL, Coco R, Hopkins J, Fitzke FW, Bird AC. Source: American Journal of Ophthalmology. 2002 March; 133(3): 341-9.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11860971&dopt=Abstract

•Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium.

Author(s): Allikmets R.

Source: American Journal of Human Genetics. 2000 August; 67(2): 487-91. Epub 2000 July 03. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10880298&dopt=Abstract

•Further pathophysiological insights into age related macular degeneration.

Author(s): Lip PL, Lip GY.

Source: The British Journal of Ophthalmology. 2001 August; 85(8): 1013. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11466264&dopt=Abstract

•Gaining insight into age-related macular degeneration.

Author(s): Frock TL.

Source: Journal of the American Academy of Nurse Practitioners. 2002 May; 14(5): 20713. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12051144&dopt=Abstract

•Gamma knife treatment of subfoveal, classic neovascularization in age-related macular degeneration: a pilot study.

Author(s): Haas A, Papaefthymiou G, Langmann G, Schrottner O, Feigl B, Leber KA, Hanselmayer R, Pendl G.

Source: Journal of Neurosurgery. 2000 December; 93 Suppl 3: 172-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11143240&dopt=Abstract

78 Macular Degeneration

•Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study.

Author(s): Smith W, Mitchell P, Wang JJ.

Source: Australian and New Zealand Journal of Ophthalmology. 1997 May; 25 Suppl 1: S13-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9267614&dopt=Abstract

•Genetic association of apolipoprotein E with age-related macular degeneration.

Author(s): Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE, van Broeckhoven C, de Jong PT.

Source: American Journal of Human Genetics. 1998 July; 63(1): 200-6. Erratum In: Am J Hum Genet 1998 October; 63(4): 1252. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9634502&dopt=Abstract

•Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration.

Author(s): Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Source: American Journal of Ophthalmology. 2000 December; 130(6): 769-73.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11124296&dopt=Abstract

•Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13.

Author(s): Stone EM, Nichols BE, Streb LM, Kimura AE, Sheffield VC. Source: Nature Genetics. 1992 July; 1(4): 246-50.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1302019&dopt=Abstract

•Genetic susceptibility to age related macular degeneration.

Author(s): Yates JR, Moore AT.

Source: Journal of Medical Genetics. 2000 February; 37(2): 83-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10662806&dopt=Abstract

•Genetics of macular dystrophies and implications for age-related macular degeneration.

Author(s): Klaver CC, Allikmets R.

Source: Dev Ophthalmol. 2003; 37: 155-69. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12876836&dopt=Abstract

•Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings.

Author(s): Bernstein PS, Leppert M, Singh N, Dean M, Lewis RA, Lupski JR, Allikmets R, Seddon JM.

Source: Investigative Ophthalmology & Visual Science. 2002 February; 43(2): 466-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11818392&dopt=Abstract

Studies 79

•Giant neurosensory detachments associated with disciform lesions in neovascular age related macular degeneration.

Author(s): Apte RS, Sung JU, DiBernardo C, Feuer-Greenberg E. Source: The British Journal of Ophthalmology. 2003 June; 87(6): 795-6.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12770991&dopt=Abstract

•Ginkgo biloba extract for age-related macular degeneration.

Author(s): Cochrane Database Syst Rev. 2001;(3):CD002030 Source: Cochrane Database Syst Rev. 2000; (2): Cd001775. Review.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11687007

•Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes.

Author(s): Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P Jr, Reed RL, Jones DP.

Source: Free Radical Biology & Medicine. 1998 March 15; 24(5): 699-704. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9586798&dopt=Abstract

•Grading of infrared confocal scanning laser tomography and video displays of digitized color slides in exudative age-related macular degeneration.

Author(s): Miura M, Elsner AE, Beausencourt E, Kunze C, Hartnett ME, Lashkari K, Trempe CL.

Source: Retina (Philadelphia, Pa.). 2002 June; 22(3): 300-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12055463&dopt=Abstract

•Granulomatous reaction to Bruch's membrane in age-related macular degeneration.

Author(s): Dastgheib K, Green WR.

Source: Archives of Ophthalmology. 1994 June; 112(6): 813-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7516148&dopt=Abstract

•Grid laser treatment of occult choroidal neovascularization in age related macular degeneration.

Author(s): Cardillo Piccolino F, Ghiglione D, Allegri P. Source: International Ophthalmology. 1993 April; 17(2): 77-83.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7691775&dopt=Abstract

•Growth factor localization in choroidal neovascular membranes of age-related macular degeneration.

Author(s): Amin R, Puklin JE, Frank RN.

Source: Investigative Ophthalmology & Visual Science. 1994 July; 35(8): 3178-88. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7519180&dopt=Abstract

80 Macular Degeneration

•Growth factors in age-related macular degeneration.

Author(s): Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Source: Ophthalmic Research. 1999; 31(3): 243-4.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10224509&dopt=Abstract

•Growth factors in age-related macular degeneration: pathogenic and therapeutic implications.

Author(s): Frank RN.

Source: Ophthalmic Research. 1997; 29(5): 341-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9323725&dopt=Abstract

•Growth rate of subretinal neovascularization in age-related macular degeneration.

Author(s): Vander JF, Morgan CM, Schatz H.

Source: Ophthalmology. 1989 September; 96(9): 1422-6; Discussion 1426-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2476701&dopt=Abstract

•Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.

Author(s): Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators.

Source: Retina (Philadelphia, Pa.). 2002 February; 22(1): 6-18. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11884872&dopt=Abstract

•Haptoglobin phenotype in age-related macular degeneration patients.

Author(s): Seider N, Beiran I, Miller-Lotan R, Dori D, Karp J, Miller B, Levy AP. Source: American Journal of Ophthalmology. 2003 November; 136(5): 911-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14597045&dopt=Abstract

•Health maintenance issues of the elderly. Vision: age-related macular degeneration.

Author(s): Bressler SB.

Source: Md Med J. 1989 February; 38(2): 135-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2915618&dopt=Abstract

•Help for macular degeneration.

Author(s): McDonald HR.

Source: Health News. 1999 December 15; 5(15): 1-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10633581&dopt=Abstract

Studies 81

•Hereditary hypotrichosis (Marie-Unna type) and juvenile macular degeneration (Stargardt's maculopathy).

Author(s): Marren P, Wilson C, Dawber RP, Walshe MM.

Source: Clinical and Experimental Dermatology. 1992 May; 17(3): 189-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1451298&dopt=Abstract

•Hereditary macular degeneration in three generations.

Author(s): Johnston SS, Darragh J, Nevin NC.

Source: The British Journal of Ophthalmology. 1973 August; 57(8): 578-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4743920&dopt=Abstract

•Hereditary macular degeneration--a population survey in the country of Vsterbotten, Sweden.

Author(s): Nordstrom S.

Source: Hereditas. 1974; 78(1): 41-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4448697&dopt=Abstract

•Hereditary vitelliform macular degeneration: variable fundus findings within a single pedigree.

Author(s): Maloney WF, Robertson DM, Duboff SM. Source: Archives of Ophthalmology. 1977 June; 95(6): 979-83.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=869756&dopt=Abstract

•Heredity and age-related macular degeneration. Observations in monozygotic twins.

Author(s): Klein ML, Mauldin WM, Stoumbos VD.

Source: Archives of Ophthalmology. 1994 July; 112(7): 932-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8031273&dopt=Abstract

•High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration.

Author(s): Bischoff PM, Flower RW.

Source: American Journal of Ophthalmology. 1983 September; 96(3): 398-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6614118&dopt=Abstract

•High-dose supplements for age-related macular degeneration: did you leave out centrum?

Author(s): Abramson DH, Abramson HS.

Source: Archives of Ophthalmology. 2002 November; 120(11): 1602. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12427092&dopt=Abstract

82 Macular Degeneration

•High-risk characteristics of fellow eyes of patients with unilateral neovascular agerelated macular degeneration.

Author(s): Sandberg MA, Weiner A, Miller S, Gaudio AR. Source: Ophthalmology. 1998 March; 105(3): 441-7.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9499774&dopt=Abstract

•Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.

Author(s): Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Source: Survey of Ophthalmology. 1999 October; 44 Suppl 1: S10-32.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10548114&dopt=Abstract

•Histologic features of the early stages of age-related macular degeneration. A statistical analysis.

Author(s): van der Schaft TL, Mooy CM, de Bruijn WC, Oron FG, Mulder PG, de Jong PT.

Source: Ophthalmology. 1992 February; 99(2): 278-86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1553220&dopt=Abstract

•Histopathology of age-related macular degeneration.

Author(s): Green WR.

Source: Molecular Vision [electronic Resource]. 1999 November 3; 5: 27. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10562651&dopt=Abstract

•Hot spots after photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

Author(s): Battaglia Parodi M, Da Pozzo S.

Source: Retina (Philadelphia, Pa.). 2002 October; 22(5): 671-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12441743&dopt=Abstract

•Hot spots in age-related macular degeneration.

Author(s): Da Pozzo S.

Source: Ophthalmology. 2000 July; 107(7): 1212-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10889072&dopt=Abstract

•How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Author(s): Owen CG, Fletcher AE, Donoghue M, Rudnicka AR.

Source: The British Journal of Ophthalmology. 2003 March; 87(3): 312-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12598445&dopt=Abstract

Studies 83

•Hyperacuity test to evaluate vision through dense cataracts; research preliminary to a clinical study. IV. Data on patients with macular degeneration and minimal media disorders obtained with and without a pseudo-nuclear cataract 6/60 (20/200) at the Aravind Eye Hospital, Madurai, India.

Author(s): Singh S, Aravind S, Hirose H, Enoch JM, Azen SP.

Source: Optometry and Vision Science : Official Publication of the American Academy of Optometry. 1996 February; 73(2): 125-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8927313&dopt=Abstract

•Hyperopia and neovascularization in age-related macular degeneration.

Author(s): Sandberg MA, Tolentino MJ, Miller S, Berson EL, Gaudio AR. Source: Ophthalmology. 1993 July; 100(7): 1009-13.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7686644&dopt=Abstract

•Hypertension, cardiovascular disease, and age-related macular degeneration. AgeRelated Macular Degeneration Risk Factors Study Group.

Author(s): Hyman L, Schachat AP, He Q, Leske MC.

Source: Archives of Ophthalmology. 2000 March; 118(3): 351-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10721957&dopt=Abstract

•Identification of lesion components that influence visual function in age related macular degeneration.

Author(s): Hogg R, Curry E, Muldrew A, Winder J, Stevenson M, McClure M, Chakravarthy U.

Source: The British Journal of Ophthalmology. 2003 May; 87(5): 609-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12714405&dopt=Abstract

•IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a.

Author(s): Ross C, Engler CB, Sander B, Bendtzen K.

Source: Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research. 2002 April; 22(4): 421-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12034024&dopt=Abstract

•Iloprost for age-related macular degeneration: long-term efficacy evaluation.

Author(s): Gaetani E, Flex A, Pola P, Pola R.

Source: Journal of the American Geriatrics Society. 2002 April; 50(4): 780-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11982690&dopt=Abstract

84 Macular Degeneration

•Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

Author(s): Bora PS, Hu Z, Tezel TH, Sohn JH, Kang SG, Cruz JM, Bora NS, Garen A, Kaplan HJ.

Source: Proceedings of the National Academy of Sciences of the United States of America. 2003 March 4; 100(5): 2679-84. Epub 2003 February 14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12589025&dopt=Abstract

•Impact of graphical user interface screen features on computer task accuracy and speed in a cohort of patients with age-related macular degeneration.

Author(s): Scott IU, Feuer WJ, Jacko JA.

Source: American Journal of Ophthalmology. 2002 December; 134(6): 857-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12470754&dopt=Abstract

•Impact of visual function on computer task accuracy and reaction time in a cohort of patients with age-related macular degeneration.

Author(s): Cochrane Database Syst Rev. 2002;(2):CD000254

Source: American Journal of Ophthalmology. 2002 March; 133(3): 350-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12076389

•Incidence of exudative age-related macular degeneration among elderly Americans.

Author(s): Javitt JC, Zhou Z, Maguire MG, Fine SL, Willke RJ. Source: Ophthalmology. 2003 August; 110(8): 1534-9.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12917168&dopt=Abstract

•Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report.

Author(s): Fujii GY, de Juan E Jr, Pieramici DJ, Humayun MS, Phillips S, Reynolds SM, Melia M, Schachat AP.

Source: American Journal of Ophthalmology. 2002 July; 134(1): 69-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12095810&dopt=Abstract

•Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.

Author(s): Lambooij AC, van Wely KH, Lindenbergh-Kortleve DJ, Kuijpers RW, Kliffen M, Mooy CM.

Source: Investigative Ophthalmology & Visual Science. 2003 May; 44(5): 2192-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12714661&dopt=Abstract

Studies 85

•Interand intra-observer variability in grading lesions of age-related maculopathy and macular degeneration.

Author(s): Scholl HP, Peto T, Dandekar S, Bunce C, Xing W, Jenkins S, Bird AC.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2003 January; 241(1): 39-47. Epub 2002 December 18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12545291&dopt=Abstract

•Interaction of A2E with model membranes. Implications to the pathogenesis of agerelated macular degeneration.

Author(s): De S, Sakmar TP.

Source: The Journal of General Physiology. 2002 August; 120(2): 147-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12149277&dopt=Abstract

•Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative macular degeneration.

Author(s): Djalilian AR, Cantrill HC, Samuelson TW. Source: Eur J Ophthalmol. 2003 January-February; 13(1): 96-8.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12635684&dopt=Abstract

•Intraocular microablation of choroidal tissue by a 308 nm AIDA excimer laser for RPE-transplantation in patients with age-related macular degeneration.

Author(s): Holz FG, Bindewald A, Schutt F, Specht H. Source: Biomed Tech (Berl). 2003 April; 48(4): 82-5.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12749285&dopt=Abstract

•Intraoperative light toxicity: a possible explanation for the association between cataract surgery and age-related macular degeneration.

Author(s): Libre PE.

Source: American Journal of Ophthalmology. 2003 November; 136(5): 961. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14597070&dopt=Abstract

•Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Author(s): Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Source: The British Journal of Ophthalmology. 2003 April; 87(4): 462-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12642311&dopt=Abstract

•Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.

Author(s): Ranson NT, Danis RP, Ciulla TA, Pratt L.

Source: The British Journal of Ophthalmology. 2002 May; 86(5): 527-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11973247&dopt=Abstract

86 Macular Degeneration

•Introduction of photodynamic therapy for the treatment of neovascular age-related macular degeneration: tracking a moving target.

Author(s): Foot B, Foy R, Chakravarthy U, Wormald R. Source: Eye (London, England). 2003 July; 17(5): 583-6.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12855963&dopt=Abstract

•Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels?

Author(s): Abalain JH, Carre JL, Leglise D, Robinet A, Legall F, Meskar A, Floch HH, Colin J.

Source: Clinica Chimica Acta; International Journal of Clinical Chemistry. 2002 December; 326(1-2): 97-104. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12417100&dopt=Abstract

•Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?

Author(s): Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K, Nakamura K. Source: The British Journal of Ophthalmology. 2003 May; 87(5): 523-4.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12714382&dopt=Abstract

•Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies.

Author(s): Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD. Source: American Journal of Ophthalmology. 2003 June; 135(6): 849-56.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12788126&dopt=Abstract

•JAMA patient page. Age-related macular degeneration.

Author(s): Parmet S, Lynm C, Glass RM.

Source: Jama : the Journal of the American Medical Association. 2002 November 13; 288(18): 2358. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12448423&dopt=Abstract

•Just the berries. Age-related macular degeneration.

Author(s): Hamilton JR.

Source: Can Fam Physician. 2000 December; 46(12): 2398-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11153406&dopt=Abstract

•Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population.

Author(s): Lau JT, Lee V, Fan D, Lau M, Michon J.

Source: The British Journal of Ophthalmology. 2002 October; 86(10): 1080-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12234882&dopt=Abstract

Studies 87

•Krypton laser in the management of disciform macular degeneration.

Author(s): Talbot JF, Bird AC.

Source: Trans Ophthalmol Soc U K. 1980 September; 100(3): 423-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6946633&dopt=Abstract

•Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration.

Author(s): Fine SL, Hawkins BS, Maguire MG.

Source: Archives of Ophthalmology. 1991 May; 109(5): 614-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1709001&dopt=Abstract

•Krypton laser photocoagulation of the senile disciform macular degeneration.

Author(s): Oosterhuis JA, Van Eijk AW.

Source: Bull Soc Belge Ophtalmol. 1983; 206: 27-35. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6200166&dopt=Abstract

•Lack of an association of apolipoprotein E gene polymorphisms with familial agerelated macular degeneration.

Author(s): Schultz DW, Klein ML, Humpert A, Majewski J, Schain M, Weleber RG, Ott J, Acott TS.

Source: Archives of Ophthalmology. 2003 May; 121(5): 679-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12742846&dopt=Abstract

•Lack of association of mutations of the bestrophin gene with age-related macular degeneration in non-familial Japanese patients.

Author(s): Akimoto A, Akimoto M, Kuroiwa S, Kikuchi T, Yoshimura N.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2001 January; 239(1): 66-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11271465&dopt=Abstract

•Large-spot size transpupillary thermotherapy for the treatment of occult choroidal neovascularization associated with age-related macular degeneration.

Author(s): Thach AB, Sipperley JO, Dugel PU, Sneed SR, Park DW, Cornelius J. Source: Archives of Ophthalmology. 2003 June; 121(6): 817-20.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12796252&dopt=Abstract

•Laser photocoagulation of neovascular lesions in senile macular degeneration.

Author(s): Striga M, Mandic Z, Ivekovic R. Source: Acta Med Croatica. 1997; 51(4-5): 203-9.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9473799&dopt=Abstract

88 Macular Degeneration

•Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function.

Author(s): Guymer RH, Gross-Jendroska M, Owens SL, Bird AC, Fitzke FW. Source: Archives of Ophthalmology. 1997 May; 115(5): 595-603.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9152126&dopt=Abstract

•Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l'Age (POLA) study.

Author(s): Delcourt C, Carriere I, Ponton-Sanchez A, Fourrey S, Lacroux A, Papoz L; POLA Study Group.

Source: Archives of Ophthalmology. 2001 October; 119(10): 1463-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11594945&dopt=Abstract

•Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Author(s): D'Amico DJ, Friberg TR.

Source: American Journal of Ophthalmology. 2001 August; 132(2): 289-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11491094&dopt=Abstract

•Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Author(s): Pieramici DJ, de Juna E Jr.

Source: American Journal of Ophthalmology. 2001 July; 132(1): 139-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11460828&dopt=Abstract

•Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Author(s): Pieramici DJ, De Juan E Jr, Fujii GY, Reynolds SM, Melia M, Humayun MS, Schachat AP, Hartranft CD.

Source: American Journal of Ophthalmology. 2000 October; 130(4): 419-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11024414&dopt=Abstract

•Limited macular translocation for subfoveal choroidal neovascularization in agerelated macular degeneration.

Author(s): Chang AA, Tan W, Beaumont PE, Zeldovich A.

Source: Clinical & Experimental Ophthalmology. 2003 April; 31(2): 103-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12648041&dopt=Abstract

•Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration.

Author(s): Hesse L, Meitinger D, Schmidt J.

Source: Ger J Ophthalmol. 1996 November; 5(6): 479-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9479539&dopt=Abstract

Studies 89

•Living with macular degeneration: creative strategies used by older women.

Author(s): Moore LW.

Source: J Ophthalmic Nurs Technol. 1999 September-October; 18(5): 200-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10847047&dopt=Abstract

•Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration.

Author(s): Mauget-Faysse M, Chiquet C, Milea D, Romestaing P, Gerard JP, Martin P, Koenig F.

Source: The British Journal of Ophthalmology. 1999 August; 83(8): 923-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10413694&dopt=Abstract

•Long term warfarin associated with bilateral blindness in a patient with atrial fibrillation and macular degeneration.

Author(s): Ung T, James M, Gray RH.

Source: Heart (British Cardiac Society). 2003 September; 89(9): 985. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12923003&dopt=Abstract

•Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration.

Author(s): Mandai M, Takahashi M, Miyamoto H, Hiroshiba N, Kimura H, Ogura Y, Honda Y, Sasai K.

Source: Japanese Journal of Ophthalmology. 2000 September-October; 44(5): 530-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11033133&dopt=Abstract

•Low dose radiation for subfoveal choroidal neovascularization in age-related macular degeneration. A pilot study: radiotherapy for age-related macular degeneration.

Author(s): Valmaggia C, Bischoff P, Ries G, Seelentag W, Niederberger H, Speiser P. Source: Documenta Ophthalmologica. Advances in Ophthalmology. 1997; 93(4): 317-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9665289&dopt=Abstract

•Low vision rehabilitation in patients with age-related macular degeneration at a tertiary eye care centre in southern India.

Author(s): Khan SA, Das T, Kumar SM, Nutheti R.

Source: Clinical & Experimental Ophthalmology. 2002 December; 30(6): 404-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12427230&dopt=Abstract

90 Macular Degeneration

•Low-dose radiation therapy for age-related macular degeneration.

Author(s): Postgens H, Bodanowitz S, Kroll P.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1997 October; 235(10): 656-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9349951&dopt=Abstract

•Low-dose radiotherapy for macular degeneration.

Author(s): Sagerman RH, Gorty SG.

Source: Front Radiat Ther Oncol. 2001; 35: 67-78. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11351955&dopt=Abstract

•Lutein and zeaxanthin status and risk of age-related macular degeneration.

Author(s): Gale CR, Hall NF, Phillips DI, Martyn CN.

Source: Investigative Ophthalmology & Visual Science. 2003 June; 44(6): 2461-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12766044&dopt=Abstract

•Macular infarction after transpupillary thermotherapy for subfoveal choroidal neovascularization in age-related macular degeneration.

Author(s): Benner JD, Ahuja RM, Butler JW.

Source: American Journal of Ophthalmology. 2002 November; 134(5): 765-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12429257&dopt=Abstract

•Macular translocation in nonexudative age-related macular degeneration.

Author(s): Eckardt C, Eckardt U.

Source: Retina (Philadelphia, Pa.). 2002 December; 22(6): 786-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12476108&dopt=Abstract

•Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization.

Author(s): Pertile G, Claes C.

Source: American Journal of Ophthalmology. 2002 October; 134(4): 560-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12383813&dopt=Abstract

•Macular translocation with 360-degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization.

Author(s): Aisenbrey S, Bartz-Schmidt U.

Source: American Journal of Ophthalmology. 2003 May; 135(5): 748-9; Author Reply 749. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12719108&dopt=Abstract

Studies 91

•Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane.

Author(s): Hahn P, Milam AH, Dunaief JL.

Source: Archives of Ophthalmology. 2003 August; 121(8): 1099-105. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12912686&dopt=Abstract

•Management of age related macular degeneration: still room for improvement.

Author(s): Howe LJ.

Source: The British Journal of Ophthalmology. 2003 March; 87(3): 375. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12598473&dopt=Abstract

•Management of ocular torsion and diplopia after macular translocation for agerelated macular degeneration: prospective clinical study.

Author(s): Freedman SF, Holgado S, Enyedi LB, Toth CA.

Source: American Journal of Ophthalmology. 2003 October; 136(4): 640-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14516803&dopt=Abstract

•Mechanism of macular degeneration starts to appear.

Author(s): Lawrence DM.

Source: Lancet. 2002 October 26; 360(9342): 1307. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12414213&dopt=Abstract

•Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study.

Author(s): Feher J, Papale A, Mannino G, Gualdi L, Balacco Gabrieli C.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2003 September-October; 217(5): 351-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12913326&dopt=Abstract

•Monitoring retinal function during transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration.

Author(s): Falsini B, Focosi F, Molle F, Manganelli C, Iarossi G, Fadda A, Dorin G, Mainster MA.

Source: Investigative Ophthalmology & Visual Science. 2003 May; 44(5): 2133-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12714653&dopt=Abstract

•Morphometric analysis of the macula in eyes with disciform age-related macular degeneration.

Author(s): Kim SY, Sadda S, Pearlman J, Humayun MS, de Juan E Jr, Melia BM, Green WR.

Source: Retina (Philadelphia, Pa.). 2002 August; 22(4): 471-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12172115&dopt=Abstract

92 Macular Degeneration

•Morphometric analysis of the macula in eyes with geographic atrophy due to agerelated macular degeneration.

Author(s): Kim SY, Sadda S, Humayun MS, de Juan E Jr, Melia BM, Green WR. Source: Retina (Philadelphia, Pa.). 2002 August; 22(4): 464-70.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12172114&dopt=Abstract

•Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.

Author(s): Pulido JS; Multicenter Investigation of Rheopheresis for AMD (MIRA-1) Study Group.

Source: Trans Am Ophthalmol Soc. 2002; 100: 85-106; Discussion 106-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12545682&dopt=Abstract

•Natural history of macular subretinal hemorrhage in age-related macular degeneration.

Author(s): Scupola A, Coscas G, Soubrane G, Balestrazzi E.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 1999; 213(2): 97-102. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9885385&dopt=Abstract

•Neovascular age-related macular degeneration and its relationship to antioxidant intake.

Author(s): Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Source: Acta Ophthalmologica Scandinavica. 2002 August; 80(4): 368-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12190777&dopt=Abstract

•Neovascular age-related macular degeneration: present and future treatment options.

Author(s): Votruba M, Gregor Z.

Source: Eye (London, England). 2001 June; 15(Pt 3): 424-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11450768&dopt=Abstract

•Neuroticism predicts depression and disability in age-related macular degeneration.

Author(s): Rovner BW, Casten RJ.

Source: Journal of the American Geriatrics Society. 2001 August; 49(8): 1097-100. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11555073&dopt=Abstract

•New insights and new approaches toward the study of age-related macular degeneration.

Author(s): Bok D.

Source: Proceedings of the National Academy of Sciences of the United States of America. 2002 November 12; 99(23): 14619-21. Epub 2002 Nov 05. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12419853&dopt=Abstract

Studies 93

•New surgical treatments for macular degeneration.

Author(s): York J, Glaser B, Murphy R.

Source: J Ophthalmic Nurs Technol. 2000 September-October; 19(5): 250-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11933322&dopt=Abstract

•New treatments for age-related macular degeneration.

Author(s): Mittra RA.

Source: Minn Med. 2003 April; 86(4): 40-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12797657&dopt=Abstract

•NICE recommends photodynamic therapy for certain patients with macular degeneration.

Author(s): Mayor S.

Source: Bmj (Clinical Research Ed.). 2003 September 27; 327(7417): 698. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14512456&dopt=Abstract

•Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.

Author(s): Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, Ozerol E. Source: Documenta Ophthalmologica. Advances in Ophthalmology. 2003 March; 106(2): 129-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12678277&dopt=Abstract

•Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.

Author(s): Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M.

Source: Journal of Cellular Physiology. 2001 December; 189(3): 323-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11748590&dopt=Abstract

•Ocular blood flow measurements and their importance in glaucoma and age-related macular degeneration.

Author(s): Garzozi HJ, Shoham N, Chung HS, Kagemann L, Harris A. Source: Isr Med Assoc J. 2001 June; 3(6): 443-8. Review.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11433640&dopt=Abstract

•Ocular perfusion and age-related macular degeneration.

Author(s): Ciulla TA, Harris A, Martin BJ.

Source: Acta Ophthalmologica Scandinavica. 2001 April; 79(2): 108-15. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11284745&dopt=Abstract

94 Macular Degeneration

•One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration.

Author(s): Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B.

Source: The British Journal of Ophthalmology. 2003 May; 87(5): 615-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12714406&dopt=Abstract

•Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization.

Author(s): Finger PT, Berson A, Ng T, Szechter A.

Source: American Journal of Ophthalmology. 1999 February; 127(2): 170-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10030559&dopt=Abstract

•Optimizing treatment of choroidal neovascularization feeder vessels associated with age-related macular degeneration.

Author(s): Flower RW.

Source: American Journal of Ophthalmology. 2002 August; 134(2): 228-39. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12140030&dopt=Abstract

•Optokinetic nystagmus in patients with central scotomas in age related macular degeneration.

Author(s): Valmaggia C, Charlier J, Gottlob I.

Source: The British Journal of Ophthalmology. 2001 February; 85(2): 169-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11159480&dopt=Abstract

•Oral and silent reading performance with macular degeneration.

Author(s): Lovie-Kitchin JE, Bowers AR, Woods RL.

Source: Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 2000 September; 20(5): 360-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11045244&dopt=Abstract

•Oral fluorescein angiography in patients with choroidal neovascularization and macular degeneration.

Author(s): Bartsch DU, Elmusharaf A, El-Bradey M, Freeman WR.

Source: Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye. 2003 January-February; 34(1): 17-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12570000&dopt=Abstract

•Organization of the human IMPG2 gene and its evaluation as a candidate gene in age-related macular degeneration and other retinal degenerative disorders.

Author(s): Kuehn MH, Stone EM, Hageman GS.

Source: Investigative Ophthalmology & Visual Science. 2001 December; 42(13): 3123-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11726612&dopt=Abstract

Studies 95

•Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration.

Author(s): Liang FQ, Godley BF.

Source: Experimental Eye Research. 2003 April; 76(4): 397-403. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12634104&dopt=Abstract

•Perifoveal laser treatment for subfoveal choroidal neovascularization in age-related macular degeneration.

Author(s): Falcone P, Chaudhry NA, Grannum E.

Source: Ophthalmic Surgery and Lasers. 1998 November; 29(11): 933-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9824867&dopt=Abstract

•Photodynamic therapy for neovascular age-related macular degeneration.

Author(s): Wormald R, Evans J, Smeeth L, Henshaw K.

Source: Cochrane Database Syst Rev. 2003; (2): Cd002030. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12804420&dopt=Abstract

•Photodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration.

Author(s): Piermarocchi S, Lo Giudice G, Sartore M, Friede F, Segato T, Pilotto E, Midena E.

Source: American Journal of Ophthalmology. 2002 April; 133(4): 572-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931801&dopt=Abstract

•Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

Author(s): Holekamp NM, Bouck N, Volpert O.

Source: American Journal of Ophthalmology. 2002 August; 134(2): 220-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12140029&dopt=Abstract

•Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.

Author(s): Eyetech Study Group.

Source: Retina (Philadelphia, Pa.). 2002 April; 22(2): 143-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11927845&dopt=Abstract

•Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration.

Author(s): Rodanant N, Friberg TR, Cheng L, Aurora A, Bartsch D, Toyoguchi M, Corbin PS, El-Bradey MH, Freeman WR.

Source: American Journal of Ophthalmology. 2002 October; 134(4): 577-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12383815&dopt=Abstract

96 Macular Degeneration

•Presentation delay in patients affected with exudative age-related macular degeneration.

Author(s): Haddad WM, Seres A, Coscas G, Soubrane G.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 January; 240(1): 31-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11954778&dopt=Abstract

•Prevention of age related macular degeneration.

Author(s): Hall NF, Gale CR.

Source: Bmj (Clinical Research Ed.). 2002 July 6; 325(7354): 1-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12098707&dopt=Abstract

•Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio.

Author(s): Seddon JM, Cote J, Davis N, Rosner B.

Source: Archives of Ophthalmology. 2003 June; 121(6): 785-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12796248&dopt=Abstract

•Proton therapy for exudative age-related macular degeneration: a randomized, shamcontrolled clinical trial.

Author(s): Ciulla TA, Danis RP, Klein SB, Malinovsky VE, Soni PS, Pratt LM, Pugh NO, Morphis JG, Bloch C, Cameron J.

Source: American Journal of Ophthalmology. 2002 December; 134(6): 905-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12470761&dopt=Abstract

•Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Author(s): Stein JD, Brown MM, Brown GC, Hollands H, Sharma S. Source: The British Journal of Ophthalmology. 2003 January; 87(1): 8-12.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12488253&dopt=Abstract

•Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.

Author(s): Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Source: Archives of Ophthalmology. 2002 April; 120(4): 481-4.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11934322&dopt=Abstract

•Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration.

Author(s): McLeod DS, Taomoto M, Otsuji T, Green WR, Sunness JS, Lutty GA. Source: Investigative Ophthalmology & Visual Science. 2002 June; 43(6): 1986-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12037009&dopt=Abstract

Studies 97

•Radiotherapy and the treatment of age-related macular degeneration. External beam radiation therapy is effective in the treatment of age-related macular degeneration.

Author(s): Finger PT, Chakravarthy U, Augsburger JJ.

Source: Archives of Ophthalmology. 1998 November; 116(11): 1507-11. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9823353&dopt=Abstract

•Radiotherapy for age-related macular degeneration.

Author(s): Gibbs SJ, Bird AC, Owens S, Plowman PN.

Source: Clin Oncol (R Coll Radiol). 1998; 10(6): 356-60. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9890535&dopt=Abstract

•Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapy.

Author(s): Ciulla TA.

Source: Acta Ophthalmologica Scandinavica. 2003 April; 81(2): 103-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12752045&dopt=Abstract

•Relation between size at birth and risk of age-related macular degeneration.

Author(s): Hall NF, Gale CR, Syddall H, Martyn CN, Phillips DI.

Source: Investigative Ophthalmology & Visual Science. 2002 December; 43(12): 3641-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12454030&dopt=Abstract

•Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration.

Author(s): Jonas JB, Kreissig I, Degenring R.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 October; 240(10): 873-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12530461&dopt=Abstract

•Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration.

Author(s): Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E, Alster Y, Rafaeli O, Avni I, Yassur Y.

Source: Ophthalmology. 2003 May; 110(5): 966-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12750099&dopt=Abstract

•Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.

Author(s): Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W.

Source: Ophthalmology. 2002 October; 109(10): 1780-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12359594&dopt=Abstract

98 Macular Degeneration

•Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration.

Author(s): Theodossiadis GP, Panagiotidis D, Georgalas IG, Moschos M, Theodossiadis PG.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2003 January; 241(1): 13-8. Epub 2002 December 05. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12545287&dopt=Abstract

•Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization: a clinicopathologic case report.

Author(s): Grossniklaus HE, Brooks HL Jr, Sippy BD, Liu P. Source: Retina (Philadelphia, Pa.). 2002 December; 22(6): 818-24.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12476118&dopt=Abstract

•Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.

Author(s): Wang JJ, Foran S, Smith W, Mitchell P.

Source: Archives of Ophthalmology. 2003 May; 121(5): 658-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12742843&dopt=Abstract

•Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration.

Author(s): Ergun E, Maar N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Source: Ophthalmology. 2003 January; 110(1): 65-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12511348&dopt=Abstract

•Self-management improves functioning for age-related macular degeneration patients.

Author(s): Rollins G.

Source: Rep Med Guidel Outcomes Res. 2003 January 10; 14(1): 9-10, 12. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12762306&dopt=Abstract

•Self-management of age-related macular degeneration and quality of life: a randomized controlled trial.

Author(s): Brody BL, Roch-Levecq AC, Gamst AC, Maclean K, Kaplan RM, Brown SI. Source: Archives of Ophthalmology. 2002 November; 120(11): 1477-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12427060&dopt=Abstract

Studies 99

•Serological association between Chlamydia pneumoniae infection and age-related macular degeneration.

Author(s): Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Source: Archives of Ophthalmology. 2003 April; 121(4): 478-82.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12695244&dopt=Abstract

•Serum leptin concentrations are decreased and correlated with disease severity in agerelated macular degeneration: a preliminary study.

Author(s): Evereklioglu C, Doganay S, Er H, Cekmen M, Ozerol E, Otlu B. Source: Eye (London, England). 2003 April; 17(3): 350-5.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12724698&dopt=Abstract

•Side effects after radiotherapy of age-related macular degeneration with the Nijmegen technique.

Author(s): Hoyng CB, Tromp AI, Meulendijks CF, Leys A, van der Maazen RW, Deutman AF, Vingerling JR.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 May; 240(5): 337-41. Epub 2002 March 23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12073055&dopt=Abstract

•Spontaneous suprachoroidal haemorrhage in a patient with age-related macular degeneration on excessive anticoagulation therapy.

Author(s): Knox FA, Johnston PB.

Source: Eye (London, England). 2002 September; 16(5): 669-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12194098&dopt=Abstract

•Spontaneous suprachoroidal hemorrhage in age-related macular degeneration presenting as angle-closure glaucoma.

Author(s): Alexandrakis G, Chaudhry NA, Liggett PE, Weitzman M. Source: Retina (Philadelphia, Pa.). 1998; 18(5): 485-6.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9801053&dopt=Abstract

•Status of therapies in development for the treatment of age-related macular degeneration.

Author(s): Hunt DW, Margaron P.

Source: Idrugs. 2003 May; 6(5): 464-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12789601&dopt=Abstract

100 Macular Degeneration

•Sub-retinal neovascular membrane in exudative macular degeneration.

Author(s): Harris S.

Source: Clinical & Experimental Optometry : Journal of the Australian Optometrical Association. 2003 January; 86(1): 51-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12568652&dopt=Abstract

•The burden of age-related macular degeneration: results of a cohort study in two French referral centres.

Author(s): Bonastre J, Le Pen C, Soubrane G, Quentel G. Source: Pharmacoeconomics. 2003; 21(3): 181-90.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12558468&dopt=Abstract

•The effect of a lower blood pressure on choroidal filling in age-related macular degeneration.

Author(s): Gaudio AR, Sandberg MA.

Source: Retina (Philadelphia, Pa.). 1998; 18(5): 439-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9801040&dopt=Abstract

•The effect of membrane differential filtration on the colloid osmotic pressure in patients with age-related macular degeneration: significance to visual function?

Author(s): Luke C, Widder RA, Walter P, Brunner R, Kirchhof B, Borberg H. Source: Therap Apher Dial. 2003 April; 7(2): 263-8.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12918954&dopt=Abstract

•The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration.

Author(s): Harris A, Ciulla TA, Pratt LM, Rechtman E, Kagemann L, Piper HC, Garzozi HJ.

Source: The British Journal of Ophthalmology. 2003 June; 87(6): 753-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12770975&dopt=Abstract

•The genetics of age-related macular degeneration.

Author(s): Conley YP, Gorin MB.

Source: Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses. 2003 August; 12(4): 238-41, 259. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14515603&dopt=Abstract

•The short-wavelength mechanisms of Stiles in age-related macular degeneration.

Author(s): Hubschman JP, Vola JL, Conrath J, Berros P, Hougrand F. Source: Vision Research. 1998 November; 38(21): 3433-40.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9893861&dopt=Abstract

Studies 101

•Therapy for macular degeneration: insights from acne.

Author(s): Sparrow JR.

Source: Proceedings of the National Academy of Sciences of the United States of America. 2003 April 15; 100(8): 4353-4. Epub 2003 Apr 07. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12682280&dopt=Abstract

•Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up.

Author(s): Algvere PV, Libert C, Lindgarde G, Seregard S.

Source: Acta Ophthalmologica Scandinavica. 2003 April; 81(2): 110-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12752047&dopt=Abstract

•Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection.

Author(s): Gross-Jendroska M, Flaxel CJ, Schwartz SD, Holz FG, Fitzke FW, Gabel VP, Bird AC.

Source: Australian and New Zealand Journal of Ophthalmology. 1998 November; 26(4): 311-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9843259&dopt=Abstract

•Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.

Author(s): Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH.

Source: Proceedings of the National Academy of Sciences of the United States of America. 2003 April 15; 100(8): 4742-7. Epub 2003 Apr 01. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12671074&dopt=Abstract

•Ultrastructural immunocytochemistry of subretinal neovascular membranes in agerelated macular degeneration.

Author(s): Das A, Puklin JE, Frank RN, Zhang NL. Source: Ophthalmology. 1992 September; 99(9): 1368-76.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1407971&dopt=Abstract

•Ultrastructure of Bruch's membrane in senile macular degeneration.

Author(s): Tarkkanen A, Vannas S.

Source: Acta Ophthalmol (Copenh). 1967; 45(5): 694-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5630839&dopt=Abstract

•Understanding macular degeneration.

Author(s): York J, Glaser B, Murphy R.

Source: J Ophthalmic Nurs Technol. 2000 May-June; 19(3): 116-9. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11249240&dopt=Abstract

102 Macular Degeneration

•Unusual visual evoked potentials in patients with age-related macular degeneration.

Author(s): Walter P, Konigsfeld P, Soudavar F, Brunner R.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2000 September-October; 214(5): 312-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10965243&dopt=Abstract

•Update in retina: photodynamic therapy for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Author(s): Sharma S.

Source: Can J Ophthalmol. 2001 February; 36(1): 7-10. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11227391&dopt=Abstract

•Urinary metabolic studies in hereditary macular degeneration.

Author(s): Holmgren G, Nordstrom S, Thorburn W.

Source: Acta Ophthalmol (Copenh). 1974; 52(2): 225-30. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4406782&dopt=Abstract

•Use of a macular buckle in the treatment of exudative age-related macular degeneration.

Author(s): Peyman GA, Conway MD, Recasens MA, Peralta E, Kertes PJ, Greve MD, ElDessouky ES.

Source: Ophthalmic Surgery and Lasers. 1999 September-October; 30(8): 619-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10507564&dopt=Abstract

•Use of a simulator with CT option in radiotherapy of macular degeneration.

Author(s): Vinh-Hung V, Verellen D, Van de Steene J, Nys F, Bijdekerke P, Linthout N, Claassens CP, Storme G.

Source: International Journal of Radiation Oncology, Biology, Physics. 1998 June 1; 41(3): 721-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9635725&dopt=Abstract

•Use of radiation in the treatment of age-related macular degeneration.

Author(s): Flaxel CJ.

Source: Ophthalmology Clinics of North America. 2002 December; 15(4): 437-44, V. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12515075&dopt=Abstract

•Utility values and age-related macular degeneration.

Author(s): Brown GC, Sharma S, Brown MM, Kistler J.

Source: Archives of Ophthalmology. 2000 January; 118(1): 47-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10636413&dopt=Abstract

Studies 103

•Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration.

Author(s): Kaiser RS, Berger JW, Williams GA, Tolentino MJ, Maguire AM, Alexander J, Madjarov B, Margherio RM.

Source: Retina (Philadelphia, Pa.). 2002 December; 22(6): 683-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12476092&dopt=Abstract

•Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

Author(s): Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Source: Archives of Ophthalmology. 2002 October; 120(10): 1307-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12365909&dopt=Abstract

•Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration.

Author(s): Jonas JB.

Source: American Journal of Ophthalmology. 2002 June; 133(6): 857; Author Reply 857-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12036694&dopt=Abstract

•Verteporfin therapy of subfoveal choroidal neovascularization in patients with agerelated macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Author(s): Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Source: Archives of Ophthalmology. 2002 November; 120(11): 1443-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12427056&dopt=Abstract

•Vision and mobility performance of subjects with age-related macular degeneration.

Author(s): Hassan SE, Lovie-Kitchin JE, Woods RL.

Source: Optometry and Vision Science : Official Publication of the American Academy of Optometry. 2002 November; 79(11): 697-707. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12462538&dopt=Abstract

•Visual function index (VF-14) in exudative age-related macular degeneration of long duration.

Author(s): Riusala A, Sarna S, Immonen I.

Source: American Journal of Ophthalmology. 2003 February; 135(2): 206-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12566025&dopt=Abstract

104 Macular Degeneration

•Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration.

Author(s): Cohen SY, Bulik A, Tadayoni R, Quentel G.

Source: The British Journal of Ophthalmology. 2003 August; 87(8): 977-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12881339&dopt=Abstract

•Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration.

Author(s): Hart PM, Chakravarthy U, Mackenzie G, Chisholm IH, Bird AC, Stevenson MR, Owens SL, Hall V, Houston RF, McCulloch DW, Plowman N.

Source: Archives of Ophthalmology. 2002 August; 120(8): 1029-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12149056&dopt=Abstract

•Visual prognosis of second eyes in patients with unilateral late exudative age-related macular degeneration.

Author(s): Pauleikhoff D, Radermacher M, Spital G, Muller C, Brumm G, Lommatzsch A, Bird AC.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 July; 240(7): 539-42. Epub 2002 June 27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12136283&dopt=Abstract

•Vitamin E supplementation and macular degeneration: randomised controlled trial.

Author(s): Taylor HR, Tikellis G, Robman LD, McCarty CA, McNeil JJ. Source: Bmj (Clinical Research Ed.). 2002 July 6; 325(7354): 11.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12098721&dopt=Abstract

•Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration.

Author(s): Lopez PF, Lambert HM, Grossniklaus HE, Sternberg P Jr. Source: Ophthalmology. 1993 March; 100(3): 415-22.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7681555&dopt=Abstract

•Wet-type macular degeneration.

Author(s): Thompson J, Daniels C.

Source: Radiol Technol. 1998 September-October; 70(1): 85-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9779511&dopt=Abstract

Studies 105

•What can we learn about age-related macular degeneration from other retinal diseases?

Author(s): Zack DJ, Dean M, Molday RS, Nathans J, Redmond TM, Stone EM, Swaroop A, Valle D, Weber BH.

Source: Molecular Vision [electronic Resource]. 1999 November 3; 5: 30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10562654&dopt=Abstract

•Who should receive oral supplement treatment for age-related macular degeneration?

Author(s): McBee WL, Lindblad AS, Ferris FL 3rd.

Source: Current Opinion in Ophthalmology. 2003 June; 14(3): 159-62. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12777936&dopt=Abstract

•X-linked neurodegenerative syndrome with congenital ataxia, late-onset progressive myoclonic encephalopathy and selective macular degeneration, linked to Xp22.33pter.

Author(s): des Portes V, Bachner L, Bruls T, Beldjord C, Billuart P, Soufir N, Bienvenu T, Vinet MC, Malaspina E, Marchiani V, Bertini E, Kahn A, Franzoni E, Chelly J.

Source: American Journal of Medical Genetics. 1996 July 12; 64(1): 69-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8826451&dopt=Abstract

•X-linked recessive atrophic macular degeneration from RPGR mutation.

Author(s): Ayyagari R, Demirci FY, Liu J, Bingham EL, Stringham H, Kakuk LE, Boehnke M, Gorin MB, Richards JE, Sieving PA.

Source: Genomics. 2002 August; 80(2): 166-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12160730&dopt=Abstract

•Yellow dye laser thermotherapy of choroidal neovascularisation in age related macular degeneration.

Author(s): Beintema MR, Oosterhuis JA, Hendrikse F.

Source: The British Journal of Ophthalmology. 2001 June; 85(6): 708-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11371493&dopt=Abstract

•Young-Simpson syndrome comprising transient hypothyroidism, normal growth, macular degeneration and torticolis.

Author(s): Kondoh T, Kinoshita E, Moriuchi H, Niikawa N, Matsumoto T, Masuno M. Source: American Journal of Medical Genetics. 2000 January 3; 90(1): 85-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10602125&dopt=Abstract

•Zinc and copper metabolism in patients with senile macular degeneration.

Author(s): Silverstone BZ, Landau L, Berson D, Sternbuch J. Source: Ann Ophthalmol. 1985 July; 17(7): 419-22.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4037602&dopt=Abstract

106 Macular Degeneration

•Zinc and macular degeneration.

Author(s): Beaumont P.

Source: Archives of Ophthalmology. 1993 August; 111(8): 1023. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8352678&dopt=Abstract

•Zinc and macular degeneration.

Author(s): Trempe CL.

Source: Archives of Ophthalmology. 1992 November; 110(11): 1517. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1444901&dopt=Abstract